Distribution of Peripheral Blood Cells in Esophageal Cancer Patients During Concurrent Chemoradiotherapy Predicts Long-Term Locoregional Progression Hazard After Treatment (GASTO1072)

References

• Bray F , Ferlay J , Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2018;68:394–424. doi:10.3322/caac.21492 30207593
   PubMed Web of Science ®Google Scholar
• Herskovic A , Martz K , al-Sarraf M , et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med . 1992;326:1593–1598. doi:10.1056/NEJM199206113262403 1584260
   PubMed Web of Science ®Google Scholar
• Cooper JS , Guo MD , Herskovic A , et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA . 1999;281:1623–1627. doi:10.1001/jama.281.17.1623 10235156
   PubMed Web of Science ®Google Scholar
• Minsky BD , Pajak TF , Ginsberg RJ , et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol . 2002;20:1167–1174. doi:10.1200/JCO.2002.20.5.1167 11870157
   PubMed Web of Science ®Google Scholar
• Kwee RM . Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of F-18 FDG PET: a systematic review. Radiology . 2010;254:707–717. doi:10.1148/radiol.09091324 20177086
   PubMed Web of Science ®Google Scholar
• Cremonesi M , Garibaldi C , Timmerman R , et al. Interim (18)F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review. Radiother Oncol . 2017;125:200–212. doi:10.1016/j.radonc.2017.09.022 29029833
   PubMed Web of Science ®Google Scholar
• Ishihara R , Yamamoto S , Iishi H , et al. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys . 2010;76:123–129. doi:10.1016/j.ijrobp.2009.01.038 19386426
   PubMed Web of Science ®Google Scholar
• Chao YK , Tseng CK , Wen YW , et al. Using pretreatment tumor depth and length to select esophageal squamous cell carcinoma patients for nonoperative treatment after neoadjuvant chemoradiotherapy. Ann Surg Oncol . 2013;20:3000–3008. doi:10.1245/s10434-013-2962-1 23584515
   PubMed Web of Science ®Google Scholar
• Fareed KR , Kaye P , Soomro IN , et al. Biomarkers of response to therapy in oesophago-gastric cancer. Gut . 2009;58:127–143. doi:10.1136/gut.2008.155861 19091831
   PubMed Web of Science ®Google Scholar
• Knight K , Wade S , Balducci L . Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med . 2004;116(Suppl 7A):11S–26S. doi:10.1016/j.amjmed.2003.12.008
   PubMed Web of Science ®Google Scholar
• Templeton AJ , McNamara MG , Seruga B , et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst . 2014;106:dju124. doi:10.1093/jnci/dju124 24875653
   PubMedGoogle Scholar
• Templeton AJ , Ace O , McNamara MG , et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev . 2014;23:1204–1212. doi:10.1158/1055-9965.EPI-14-0146 24793958
   PubMed Web of Science ®Google Scholar
• Mao Y , Chen D , Duan S , et al. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis. Cancer Cell Int . 2018;18:201. doi:10.1186/s12935-018-0698-5 30534002
   PubMed Web of Science ®Google Scholar
• Yodying H , Matsuda A , Miyashita M , et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol . 2016;23:646–654. doi:10.1245/s10434-015-4869-5 26416715
   PubMed Web of Science ®Google Scholar
• Yoo EJ , Park JC , Kim EH , et al. Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer. Dig Liver Dis . 2014;46:846–853. doi:10.1016/j.dld.2014.05.009 24970014
   PubMedGoogle Scholar
• Cox S , Hurt C , Grenader T , Mukherjee S , Bridgewater J , Crosby T . The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol . 2017;125:154–159. doi:10.1016/j.radonc.2017.08.023 28893415
   PubMed Web of Science ®Google Scholar
• Miao C , Zhu S , Pan H , Cao X , Yuan S , Hu X . Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy. Oncotarget . 2017;8:87971–87979. doi:10.18632/oncotarget.21313 29152134
   PubMedGoogle Scholar
• Chen MF , Chen PT , Kuan FC , Chen WC . The predictive value of pretreatment neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma. Ann Surg Oncol . 2019;26:190–199. doi:10.1245/s10434-018-6944-1 30362062
   PubMed Web of Science ®Google Scholar
• Zenda S , Hironaka S , Boku N , et al. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer. Dis Esophagus . 2008;21:195–200. doi:10.1111/j.1442-2050.2007.00750.x 18430098
   PubMed Web of Science ®Google Scholar
• Apetoh L , Ghiringhelli F , Tesniere A , et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med . 2007;13:1050–1059. doi:10.1038/nm1622 17704786
   PubMed Web of Science ®Google Scholar
• Lee Y , Auh SL , Wang Y , et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood . 2009;114:589–595. doi:10.1182/blood-2009-02-206870 19349616
   PubMed Web of Science ®Google Scholar
• Swann JB , Smyth MJ . Immune surveillance of tumors. J Clin Invest . 2007;117:1137–1146. doi:10.1172/JCI31405 17476343
   PubMed Web of Science ®Google Scholar
• Reits EA , Hodge JW , Herberts CA , et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med . 2006;203:1259–1271. doi:10.1084/jem.20052494 16636135
   PubMed Web of Science ®Google Scholar
• Burnette BC , Liang H , Lee Y , et al. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res . 2011;71(7):2488–2496. doi:10.1158/0008-5472.CAN-10-2820 21300764
   PubMed Web of Science ®Google Scholar
• Diakos CI , Charles KA , McMillan DC , Clarke SJ . Cancer-related inflammation and treatment effectiveness. Lancet Oncol . 2014;15:E493–E503. doi:10.1016/S1470-2045(14)70263-3 25281468
   PubMed Web of Science ®Google Scholar
• Zhang WZ , Chen JZ , Li DR , et al. Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study. World J Gastroenterol . 2014;20:13973–13980. doi:10.3748/wjg.v20.i38.13973 25320535
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA , Therasse P , Bogaerts J , et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer . 2009;45:228–247. doi:10.1016/j.ejca.2008.10.026 19097774
   PubMed Web of Science ®Google Scholar
• Chen JZ , Guo H , Zhai TT , et al. Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study. Oncotarget . 2016;7:22711–22719. doi:10.18632/oncotarget.8050 26992206
   PubMed Web of Science ®Google Scholar
• Chowdhary M , Switchenko JM , Press RH , et al. Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neuro-Oncol . 2018;139:689–697. doi:10.1007/s11060-018-2914-5
   PubMed Web of Science ®Google Scholar
• Lin AJ , Rao YJ , Chin RI , et al. Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers. Oral Oncol . 2018;86:1–7. doi:10.1016/j.oraloncology.2018.08.008 30409288
   PubMed Web of Science ®Google Scholar
• Suh KJ , Kim SH , Kim YJ , et al. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody. Cancer Immunol Immunther . 2018;67:459–470. doi:10.1007/s00262-017-2092-x
   PubMed Web of Science ®Google Scholar
• Khunger M , Patil PD , Khunger A , et al. Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients. PLoS One . 2018;13:e0197743. doi:10.1371/journal.pone.0197743 30359383
   PubMed Web of Science ®Google Scholar
• Zhou XL , Li YQ , Zhu WG , et al. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Sci Rep . 2017;7.
   Web of Science ®Google Scholar
• Lee YJ , Lee SB , Beak SK , et al. Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer. Sci Rep . 2018;8:7565. doi:10.1038/s41598-018-25970-z 29765096
   PubMed Web of Science ®Google Scholar
• Barbetta A , Nobel TB , Sihag S , et al. Neutrophil to lymphocyte ratio as predictor of treatment response in esophageal squamous cell cancer. Ann Thorac Surg . 2018;106:864–871. doi:10.1016/j.athoracsur.2018.04.007 29738752
   PubMed Web of Science ®Google Scholar
• Davuluri R , Jiang W , Fang P , et al. Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy. Int J Radiat Oncol Biol Phys . 2017;99:128–135. doi:10.1016/j.ijrobp.2017.05.037 28816138
   PubMed Web of Science ®Google Scholar
• Fang P , Jiang W , Davuluri R , et al. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiother Oncol . 2018;128:584–590. doi:10.1016/j.radonc.2018.02.025 29530432
   PubMed Web of Science ®Google Scholar
• Feng X , Li L , Wu J , et al. complete blood count score model integrating reduced lymphocyte-monocyte ratio, elevated neutrophil-lymphocyte ratio, and elevated platelet-lymphocyte Ratio Predicts inferior clinical outcomes in Adult T-lymphoblastic lymphoma. Oncologist . 2019;24(11). doi:10.1634/theoncologist.2018-0789
   Web of Science ®Google Scholar
• Ahn GO , Tseng D , Liao CH , Dorie MJ , Czechowicz A , Brown JM . Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci U S A . 2010;107:8363–8368. doi:10.1073/pnas.0911378107 20404138
   PubMed Web of Science ®Google Scholar
• Liang H , Deng L , Hou Y , et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun . 2017;8:1736. doi:10.1038/s41467-017-01566-5 29170400
   PubMed Web of Science ®Google Scholar
• Zhang C , Zhang Z , Zhang G , et al. A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. Clin Transl Med . 2020;10:e156. doi:10.1002/ctm2.156 32898328
   PubMed Web of Science ®Google Scholar
• Luo HS , Huang SF , Xu HY , et al. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer. Radiat Oncol . 2020;15:249. doi:10.1186/s13014-020-01692-3 33121507
   PubMed Web of Science ®Google Scholar
• Wang C , Zhao K , Hu S , et al. The PET-derived tumor-to-liver standard uptake ratio (SUV TLR) is superior to tumor SUVmax in predicting tumor response and survival after chemoradiotherapy in patients with locally advanced esophageal cancer. Front Oncol . 2020;10:1630. doi:10.3389/fonc.2020.01630 33014819
   PubMed Web of Science ®Google Scholar